Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US8133893 | PRAGMA | Trazodone and trazodone hydrochloride in purified form |
Mar, 2029
(6 years from now) |
Drugs and Companies using TRAZODONE HYDROCHLORIDE ingredient
Market Authorisation Date: 25 March, 1985
Treatment: NA
Dosage: TABLET;ORAL
Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
---|---|---|---|---|
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
US8778924 | PRAGMA | Modified release amoxicillin products |
Dec, 2026
(3 years from now) | |
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US8357394 | PRAGMA | Compositions and methods for improved efficacy of penicillin-type antibiotics |
Dec, 2026
(3 years from now) | |
US8299052 | PRAGMA | Pharmaceutical compositions and methods for improved bacterial eradication |
May, 2027
(4 years from now) |
Drugs and Companies using AMOXICILLIN ingredient
Market Authorisation Date: 23 January, 2008
Treatment: Use of once-a-day amoxicillin product to treat tonsillitis and/or pharyngitis secondary to streptococcus pyogenes; Method of treating tonsillitis and/or pharyngitis secondary to streptococcus pyogenes in a once-a-day amoxicillin product
Dosage: TABLET, EXTENDED RELEASE;ORAL
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic